Specimen Collection Cards Market to See Robust Growth by 2032, According to Persistence Market Research

The global specimen collection cards market is poised for significant growth over the next decade, driven by their applications in genomics, diagnostics, and forensic science. These cards, used for collecting, storing, and transporting biological samples such as blood, saliva, and urine, are becoming indispensable tools in clinical and research settings. The market, which was valued at US$ 477.0 million in 2025, is expected to reach US$ 671.2 million by 2032, growing at a CAGR of around 5.0% during the forecast period.

In this article, we will delve into the current state of the specimen collection cards market, examine the key growth drivers, identify challenges and opportunities, and discuss the market's segmentation and regional trends. This in-depth analysis also incorporates insights from Persistence Market Research, offering a comprehensive view of what lies ahead for this rapidly evolving industry.

✅Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/35329

Overview of the Specimen Collection Cards Market

The specimen collection cards market serves several industries, including genomics, diagnostics, pharmacokinetics, and forensic science. Specimen collection cards provide a cost-effective, convenient, and non-invasive way to collect biological samples. They offer the advantage of ambient temperature storage, eliminating the need for refrigeration, which is particularly beneficial for remote and field-based research. Their ability to stabilize analytes such as DNA, RNA, and small molecules, even at room temperature, has significantly increased their demand across various clinical and research applications.

Key Growth Drivers and Market Outlook

One of the primary drivers of the specimen collection cards market growth is the increasing need for genetic testing and field research. The market is being fueled by the rising popularity of genetic testing, especially in home-based settings, and the growing demand for field-based research. The ability of specimen collection cards to preserve biological samples for long periods without refrigeration makes them ideal for remote areas and resource-limited settings. With the adoption of decentralized healthcare models and the expansion of telehealth services, specimen collection cards are becoming vital tools for large-scale screening programs and bio-banking initiatives.

Moreover, specimen collection cards are gaining traction in newborn screening programs, which has further expanded their reach. North America is expected to dominate the market in 2025, with a market share of around 35.4%. This can be attributed to the substantial investments in public health programs, the rise of at-home sample collection services, and the growing demand for forensic toxicology testing. The rising interest in multi-omics studies and direct-to-consumer genetic testing is also contributing to market growth.

Key Highlights from the Report

➤ The global market is expected to grow from US$ 477.0 million in 2025 to US$ 671.2 million by 2032, at a CAGR of 5.0%.
➤ Blood samples will account for around 88.4% of the market share in 2025 due to their versatility in molecular diagnostics.
➤ Whatman 903 is expected to dominate the market with a 41.7% share in 2025, thanks to its high analyte recovery rates.
➤ North America is set to lead the market, driven by government funding and the integration of decentralized diagnostics.
➤ The rise of telehealth and mail-in diagnostics will spur demand for user-friendly home sampling solutions.
➤ Increased demand for forensic toxicology testing will create new opportunities for dried matrix spot cards.

Market Segmentation

The specimen collection cards market is highly diversified, with growth driven by several factors, including specimen type and product category.

Specimen Type Insights
Specimen collection cards are primarily segmented based on the type of biological sample collected. Blood samples are projected to dominate the market, accounting for 88.4% of the market share in 2025. Dried Blood Spot (DBS) cards are widely used for the collection of blood, particularly in newborn screening programs, because they provide an easy, minimally invasive alternative to venipuncture. These cards are increasingly used in neonatal metabolic screening, enabling early detection of conditions such as congenital hypothyroidism.

Saliva samples are also gaining popularity due to their non-invasive nature and ease of collection. They are emerging as a reliable alternative for DNA and RNA analysis, especially in population-scale screening programs and at-home testing kits. The growing interest in genetic testing by companies like 23andMe and Myriad Genetics is expected to fuel the growth of the saliva segment. Additionally, the rising validation of saliva-based diagnostics for hormone and RNA analysis is further driving segment growth.

Product Insights
The market is also segmented by product type, with notable segments including Whatman 903, Ahlstrom 226, and FTA cards. Among these, Whatman 903 is anticipated to capture 41.7% of the market share in 2025. Known for its high analyte recovery rates and regulatory acceptance, Whatman 903 has proven performance in PCR-based assays and RNA extraction, making it a popular choice in both clinical diagnostics and field-based research.

The FTA card segment is also gaining momentum due to its ability to preserve nucleic acids for extended periods at ambient temperatures. FTA cards are used primarily in forensic science and genetic research, particularly in low-resource settings. Their ability to stabilize RNA, DNA, and other analytes makes them highly suitable for infectious disease research, where preserving sample integrity is critical.

✅Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/specimen-collection-cards-market.asp

Regional Insights

North America
North America, particularly the United States, is expected to continue leading the specimen collection cards market in 2025. This is due to the strong presence of government-funded public health initiatives and the expansion of telehealth services. In addition to newborn screening, the United States is witnessing a surge in forensic toxicology testing, with dried blood spot and urine spot cards being integrated into field testing kits for drug abuse and toxicology testing.

Middle East and Africa
In the Middle East, newborn screening programs are a significant driver of market growth. In countries like Saudi Arabia, the Ministry of Health has rolled out extensive screening programs, leading to an increased demand for DBS cards. Across sub-Saharan Africa, HIV and hepatitis surveillance programs have propelled the use of DBS cards for viral load monitoring in remote areas. These cards help bypass the need for cold-chain logistics and allow for delayed transportation of samples without degradation.

Asia-Pacific
The Asia-Pacific region is experiencing robust growth, with countries like India and China embracing specimen collection cards for large-scale disease screening programs. India's Rashtriya Bal Swasthya Karyakram and China's pharmacogenomic research are significant contributors to this trend. The adoption of DBS cards in China's rural areas for infectious disease testing further highlights the potential of specimen collection cards in underserved regions.

Market Drivers

The specimen collection cards market is primarily driven by the growing demand for genetic testing and the rising prevalence of field-based research. Additionally, decentralized healthcare models and the adoption of telehealth have spurred the need for remote diagnostics. The ability of specimen collection cards to preserve biological samples at ambient temperatures without the need for a cold chain is particularly beneficial in low-resource settings, making them indispensable in global health initiatives.

Market Restraints
One of the major challenges facing the market is hematocrit bias in dried blood spot samples. Variations in blood viscosity and cell-to-plasma ratios can affect the consistency of analyte measurements, leading to inaccuracies in quantitative assays. This issue is particularly problematic in applications like hormone testing and therapeutic drug monitoring, where precision is critical. The hematocrit bias could impede the widespread adoption of DBS cards in regulated clinical settings.

Market Opportunities
A key opportunity lies in the forensic toxicology sector. As synthetic opioids and designer drugs continue to surge, law enforcement agencies and public health organizations are increasingly turning to dried matrix spot cards for remote toxicology testing. These cards offer a tamper-evident, easy-to-store solution for biological sample collection in toxicology screenings. Furthermore, DNA collection kits for law enforcement and postmortem investigations are gaining momentum, especially in regions with limited access to centralized laboratories.

✅Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/35329

Reasons to Buy the Report

✔ Gain insights into market dynamics, including growth drivers, restraints, and opportunities.
✔ Understand regional trends and emerging markets for specimen collection cards.
✔ Explore detailed market segmentation across product types, specimen types, and end-users.
✔ Benefit from strategic insights and forecast data to make informed business decisions.
✔ Stay ahead of competitors by analyzing key market developments and competitive landscape.

Frequently Asked Questions (FAQs)

How Big is the Specimen Collection Cards Market?
Who are the Key Players in the Global Specimen Collection Cards Market?
What is the Projected Growth Rate of the Specimen Collection Cards Market?
What is the Market Forecast for Specimen Collection Cards for 2032?
Which Region is Estimated to Dominate the Specimen Collection Cards Market through the Forecast Period?

Company Insights

The specimen collection cards market is dominated by several key players, each contributing to its growth and innovation. Prominent companies in this sector include:

✦ QIAGEN N.V.
✦ PerkinElmer Inc.
✦ Danaher Corporation
✦ DBS System SA
✦ GenTegra LLC
✦ CENTOGENE N.V.
✦ Eastern Business Forms, Inc.
✦ Ahlstrom
✦ ARCHIMED Life Science GmbH
✦ FortiusBio

Recent Developments

Capitainer introduced the CapitainerSEP10 card, designed for separated blood samples. This innovative card enables at-home sampling without the need for a centrifuge.

A collaboration between Baylor College of Medicine, Medical University of South Carolina, and Capitainer aims to develop Dried Fecal Spot (DFS) cards for fecal sample collection and ambient storage.

Conclusion

The specimen collection cards market is poised for substantial growth, with a forecasted CAGR of 5.0% from 2025 to 2032. As key drivers such as genetic testing, telehealth, and decentralized diagnostics continue to reshape the healthcare landscape, specimen collection cards will play a pivotal role in advancing clinical diagnostics, forensic science, and field research. However, challenges like hematocrit bias and varying sample quality need to be addressed to unlock the full potential of this technology. The market offers promising opportunities, especially in the areas of forensic toxicology and remote diagnostics, making it an exciting space for innovation and investment.

Read Related Reports:

Neurodegenerative Disease Drugs Market https://www.persistencemarketresearch.com/market-research/neurodegenerative-disease-drugs-market.asp
Online Dermatology Consultation Market https://www.persistencemarketresearch.com/market-research/online-dermatology-consultation-market.asp
Europe Orthopedic Devices Market https://www.persistencemarketresearch.com/market-research/europe-orthopedic-devices-market.asp
U.S. Hemostats Market https://www.persistencemarketresearch.com/market-research/us-hemostats-market.asp
Leukemia Therapeutic Market https://www.persistencemarketresearch.com/market-research/leukemia-therapeutic-market.asp

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.